ID23192A - Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol - Google Patents

Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol

Info

Publication number
ID23192A
ID23192A IDW991656A ID991656A ID23192A ID 23192 A ID23192 A ID 23192A ID W991656 A IDW991656 A ID W991656A ID 991656 A ID991656 A ID 991656A ID 23192 A ID23192 A ID 23192A
Authority
ID
Indonesia
Prior art keywords
proliposoma
inhabilitation
tokoferol
stabilized
powder
Prior art date
Application number
IDW991656A
Other languages
English (en)
Inventor
Katarina Bystrom
Per-Gunnar Nilson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID23192A publication Critical patent/ID23192A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW991656A 1997-06-27 1998-06-08 Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol ID23192A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27

Publications (1)

Publication Number Publication Date
ID23192A true ID23192A (id) 2000-03-23

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991656A ID23192A (id) 1997-06-27 1998-06-08 Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol

Country Status (18)

Country Link
EP (1) EP1001749A1 (id)
JP (1) JP2002510311A (id)
KR (1) KR20010014163A (id)
CN (1) CN1260713A (id)
AU (1) AU729100B2 (id)
BR (1) BR9810280A (id)
CA (1) CA2295028A1 (id)
EE (1) EE9900601A (id)
HU (1) HUP0003207A3 (id)
ID (1) ID23192A (id)
IL (1) IL133478A0 (id)
IS (1) IS5304A (id)
NO (1) NO996439L (id)
NZ (1) NZ501672A (id)
PL (1) PL337723A1 (id)
SK (1) SK184899A3 (id)
TR (1) TR199903271T2 (id)
WO (1) WO1999000111A1 (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138310A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138313A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1888033B1 (en) * 2005-06-09 2014-02-19 Meda AB Method and composition for treating inflammatory disorders
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20160073667A1 (en) * 2013-05-06 2016-03-17 Dsm Ip Assets B.V. Powderous vitamin e formulation
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
EP3824296A4 (en) 2018-07-20 2022-04-27 Lipocine Inc. LIVER DISEASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7908791A (en) * 1990-05-08 1991-11-27 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Also Published As

Publication number Publication date
EP1001749A1 (en) 2000-05-24
IL133478A0 (en) 2001-04-30
NO996439L (no) 2000-02-28
AU729100B2 (en) 2001-01-25
NZ501672A (en) 2001-06-29
EE9900601A (et) 2000-08-15
HUP0003207A3 (en) 2001-03-28
TR199903271T2 (en) 2000-08-21
JP2002510311A (ja) 2002-04-02
KR20010014163A (ko) 2001-02-26
WO1999000111A1 (en) 1999-01-07
HUP0003207A2 (hu) 2001-02-28
IS5304A (is) 1999-12-15
SK184899A3 (en) 2000-05-16
CA2295028A1 (en) 1999-01-07
CN1260713A (zh) 2000-07-19
BR9810280A (pt) 2000-09-12
AU7945698A (en) 1999-01-19
PL337723A1 (en) 2000-08-28
NO996439D0 (no) 1999-12-23

Similar Documents

Publication Publication Date Title
ID26509A (id) Komponen-komponen yang mengandung tetrahidrolipstatin
ID26330A (id) Polipeptida-polipeptida yang bergantung vitamin k yang dimodifikasi
ID23980A (id) Bahan abrasif berstruktur yang dilekati bubuk fungsional
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID24472A (id) Pembuatan aglomerat bubuk
ID22839A (id) Kasa sumur yang dapat muai
ID26334A (id) Morfolinol yang aktif secara farmasi
ID27741A (id) Larutan teriparatide yang distabilkan
ID18427A (id) Pengkabut serbuk
ID28055A (id) Wadah-wadah yang dibawa
ID20837A (id) Mikrokapsul dengan laju pelepasan yang mudah disesuaikan
EE04707B1 (et) Pulberinhalaator
ID28692A (id) Turunan benzena dilebur yang berguna sebagai herbisida
ID23192A (id) Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol
IS5536A (is) Efnablanda fyrir snyrtivörur
ID26317A (id) Formulasi pelepasan yang diperpanjang
ID29268A (id) Senyawa spiro yang bersifat antihistamin
DE69904255D1 (de) Dosiervorrichtung
ID19658A (id) Tempat untuk tinta bubuk
DE69806324D1 (de) Futterdosiervorrichtung
DE59909560D1 (de) Pulverförder-Injektor
ID26723A (id) Komposisi yang mengandung minoksidil untuk penggunaan luar
DE59909297D1 (de) Carbonyleisensilizid-Pulver
ID16154A (id) Komposisi monomer yang distabilisasi
ID23429A (id) Komposisi-komposisi sertralina yang larut